Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Glass House BrandsGLAS -5.62%65 Cash-to-Debt is 0.26 as of Jun. 2026, which is 21% below its 10-year median of 0.33. GuruFocus rates GLAS with a GF Score™ of 65/100 and a GF Value™ of $5.12 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 983 Drug Manufacturers companies, Glass House Brands ranks worse than 68.26% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Glass House Brands's cash to debt ratio for the quarter that ended in Jun. 2026 was 0.26.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Glass House Brandscouldn't pay off its debt using the cash in hand for the quarter that ended in Jun. 2026.
The historical rank and industry rank for Glass House Brands's Cash-to-Debt or its related term are showing as below:
GLAS'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.15 Med: 0.33 Max: 45.61
Current: 0.26
During the past 6 years, Glass House Brands's highest Cash to Debt Ratio was 45.61. The lowest was 0.15. And the median was 0.33.
GLAS's Cash-to-Debt is ranked worse than 68.26% of 983
companies
in the Drug Manufacturers industry
Industry Median: 0.98
vs GLAS: 0.26
Glass House Brands (NYSE:GLAS) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
Glass House Brands Cash-to-Debt Related Terms
Glass House Brands Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for Glass House Brands's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, Glass House Brands's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Glass House Brands Cash-to-Debt vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Glass House Brands's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where Glass House Brands's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Glass House Brands (GLAS) has a Cash-to-Debt of 0.26 as of Jun. 2026. This is 21% below median its historical median of 0.33. Over the past decade, Glass House Brands' Cash-to-Debt has ranged from 0.15 to 45.61. According to the industry distribution chart, Glass House Brands ranks #671 out of 983 companies in the Drug Manufacturers industry, placing it in the top 68.3%.
Is Glass House Brands' Cash-to-Debt too high?
Glass House Brands' current Cash-to-Debt of 0.26 is 21% below median its 10-year median of 0.33. Over the past 10 years, this metric has ranged from a low of 0.15 to a high of 45.61. The Drug Manufacturers industry median Cash-to-Debt is 0.98. Glass House Brands' value of 0.26 is 73.5% below this industry median. Based on the distribution chart, Glass House Brands ranks #671 out of 983 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Glass House Brands has a GF Score™ of 65/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Glass House Brands' Cash-to-Debt compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Glass House Brands ranks #671 out of 983 companies for Cash-to-Debt. This places Glass House Brands in the lower half of its industry. The industry median Cash-to-Debt is 0.98. Glass House Brands' value of 0.26 is 73.5% below this benchmark. Historically, Glass House Brands' own Cash-to-Debt has ranged from 0.15 to 45.61 over the past decade. While the company's 10-year median is 0.33 vs. the industry median of 0.98, Glass House Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for a Drug Manufacturers company?
The median Cash-to-Debt among Drug Manufacturers companies is 0.98, based on 983 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Glass House Brands's current Cash-to-Debt of 0.26 is 73.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median Cash-to-Debt is 0.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Glass House Brands's current Cash-to-Debt is 0.26, which is 21% below median its own 10-year median of 0.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Glass House Brands stock overvalued right now?
Based on GuruFocus' analysis, Glass House Brands (GLAS) is currently considered Significantly Overvalued. The stock's GF Value™ is $5.12, compared to a current price of $9.41 — trading 83.8% above its estimated fair value. The current Cash-to-Debt is 0.26, which is 21% below median its 10-year median of 0.33 and 73.5% below the Drug Manufacturers industry median of 0.98. Glass House Brands' overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For Glass House Brands (GLAS), the current Cash-to-Debt is 0.26 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Glass House Brands (GLAS) Overvalued in 2026?
Based on GuruFocus' analysis, Glass House Brands stock appears to be overvalued.
The current stock price of $9.41 is trading 83.8% above its estimated GF Value™ of $5.12.
GuruFocus considers Glass House Brands to be Significantly Overvalued.
Key valuation signals for GLAS:
Cash-to-Debt: 0.26 (21% below median its 10-year median of 0.33)
GF Value™: $5.12 vs. price of $9.41 (83.8% above fair value)
Industry Position: 73.5% below the Drug Manufacturers median (#671 of 983)
No single metric tells the full story. See the GLAS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Glass House Brands Inc is an integrated cannabis company that operates exclusively in the state of California. Its portfolio of brands includes Glass House Farms, Forbidden Flowers, and Mama Sue Wellness. It cultivates, manufactures, and distributes cannabis bulk flower and trim to wholesalers and consumer packaged goods to third-party retail stores. It also owns and operates retail cannabis stores in the state of California. It has three reportable segments: Retail, Wholesale Biomass, and Cannabis-related consumer packaged goods. It generates the majority of its revenue from the Wholesale Biomass segment.
65GF Score
Get the complete analysis for GLAS
Cash-to-Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GLAS has been successfully added to your 
